# Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy

> **NCT01928862** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 78 (actual)

## Conditions studied

- Need for Bowel Preparation

## Interventions

- **DRUG:** Prepopik® ½ Sachet x 2 (9-12 years)
- **DRUG:** Prepopik® 1 Sachet x 2 (9-12 years)
- **DRUG:** Oral polyethylene glycol (PEG) based preparation (9-12 years)
- **DRUG:** Prepopik® 1 Sachet x 2 (13-16 years)
- **DRUG:** Oral polyethylene glycol (PEG) based preparation (13-16 years)

## Key facts

- **NCT ID:** NCT01928862
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-03
- **Primary completion:** 2017-02-15
- **Final completion:** 2017-03-16
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2018-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01928862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01928862, "Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01928862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*